Results 11 to 20 of about 26,501 (228)
Transarterial chemoembolization of hepatocellular carcinoma [PDF]
, 2014 Hepatocellular carcinoma is one of the deadliest cancers in the world and due to its growing incidence, additional focus is necessary in order to save lives. We know that majority of HCC cases occur in patients with previous cirrhotic liver. It's therefore of utmost importance to prevent diseases that can progress to cirrhosis. Due to the complexity of
Cetinić, Ivan
core +3 more sources
Technology in Cancer Research & Treatment, 2023 Background: Programmed cell death protein-1 inhibitors combined with lenvatinib have become a popular treatment option for patients with unresectable hepatocellular carcinoma.
Jinfeng Wang MM +10 more
doaj +1 more source
Radiology and Oncology, 2023 This trial aimed to compare the outcomes of drug-eluting beads transarterial chemoembolization (DEB-TACE) with CalliSpheres® microspheres (CSM) and conventional transarterial chemoembolization cTACE in the treatment of patients with unresectable ...
Shi Zhongxing +5 more
doaj +1 more source
The Annals of African Surgery, 2022 The West African subregion has a high number of cases of hepatocellular carcinoma (HCC), and this is partly because of a lack of expertise and health infrastructure for the delivery of effective locoregional therapies for patients who present with early ...
Ninalowo Hammed +2 more
doaj +1 more source
Pakistan Armed Forces Medical Journal, 2021 Objective: To assess the efficacy of intra-arterial lidocaine in peri & post-procedural pain control and the dose of narcotic analgesic required in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Study Design: Comparative
Ghulam Abbas, Atif Sheraz, Raza Rahim
doaj +1 more source
Исследования и практика в медицине, 2023 Hepatocellular carcinoma (HCC) accounts for 75% to 95% of all cases of primary liver cancer. The number of cases of newly diagnosed hepatocellular cancer (HCC) in the Russian Federation in 2019 accounted to 9324.
S. A. Ivanov +5 more
doaj +1 more source
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma [PDF]
Clinical and Molecular Hepatology, 2017 Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treatment modalities including transplant, surgical resection and locoregional therapies including ablative therapies and transarterial embolotherapies ...
Edward Wolfgang Lee, Sarah Khan
doaj +1 more source
Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats [PDF]
, 2013 AIM: To evaluate and compare the effect of combined transarterial chemoembolization (TACE) and arterial administration of Bletilla striata (a Chinese traditional medicine against liver tumor) versus TACE alone for the treatment of hepatocellular ...
Vossoughi, Daryusch +7 more
core +1 more source
Belitung Nursing Journal, 2022 Background: Post transarterial chemoembolization (post-TACE) causes side effects that impact patients, which leads to fatigue symptoms and reduced functional status. However, unrelieved fatigue and reduced functional status may cause patients to withdraw
Nawiya Yenjai +3 more
doaj +1 more source
Portal vein thrombosis and arterioportal shunts : effects on tumor response after chemoembolization of hepatocellular carcinoma [PDF]
, 2011 AIM: To evaluate the effect of portal vein thrombosis and arterioportal shunts on local tumor response in advanced cases of unresectable hepatocellular carcinoma treated by transarterial chemoembolization.
Ackermann, Hans +6 more
core +1 more source